FDA approves Inmazeb, the first Ebola treatment for children and adults

The FDA has announced its first approval for an Ebola treatment that can be used with both pediatric and adult patients infected by Zaire ebolavirus. The treatment is called Inmazeb; it is comprised of three different monoclonal antibody mixtures and works by targeting the Ebola virus’s glycoprotein, ultimately preventing the virus from entering an infected person’s cells. Ebola is a …